The Iranian Pharmacists Association has issued a stark warning about an impending pharmaceutical crisis due to the government’s failure to settle its debts with pharmacies. In a letter addressed to the Secretary of the Supreme National Security Council, the association demanded the immediate and full payment of outstanding debts, cautioning that failure to act would lead to severe disruptions in the country’s drug supply.
Mounting Debt and Financial Strain
The crisis stems from the failure of the Social Security Organization and the Targeted Subsidies Organization to fulfill their financial obligations to pharmacies. According to the Pharmacists Association, these organizations have not paid their debts for months, resulting in a critical liquidity shortage for pharmacies and the broader pharmaceutical supply chain.
Under existing regulations, insurance providers are required to pay 60 percent of outstanding claims within 15 days and the remaining 40 percent within three months. However, these payments have not been made, pushing pharmacies into financial distress. As a result, many pharmacies are struggling to sustain their operations, with an increasing number of returned checks and pharmaceutical distribution companies refusing to supply medicines to indebted pharmacies.
A Threat to Drug Availability and Affordability
The Iranian Pharmacists Association has expressed grave concerns that the continued lack of payments will lead to a significant reduction in the country’s strategic pharmaceutical reserves. If the situation persists, pharmacies may be forced to stop accepting insurance-covered prescriptions and increase drug prices, placing an additional burden on patients.
Mahmoud Najafi Arab, head of the Tehran Chamber of Commerce, echoed these concerns in a media interview, warning that the pharmaceutical industry is on the brink of paralysis. He pointed out that while the government fails to pay its debts, production costs continue to rise, yet medicine prices remain artificially low, exacerbating financial pressures on the industry.
Wider Economic Implications
Amir Farshchi, head of the Health Economy Commission of the Alborz Chamber of Commerce, highlighted that the government’s unpaid debts have not only affected pharmacies but have also disrupted the supply of medical equipment. Industry figures reveal that the pharmaceutical sector faces debts amounting to 34 trillion tomans, while the medical equipment sector’s debts stand at 20 trillion tomans.
Without urgent government intervention and a sustainable financial solution, pharmacists and pharmaceutical companies warn that they will soon be unable to supply essential medicines. The ongoing crisis underscores the pressing need for structural reforms in Iran’s healthcare financing system to prevent further deterioration of the country’s pharmaceutical industry.
